Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)
China flag China · Delayed Price · Currency is CNY
6.53
+0.14 (2.19%)
May 6, 2026, 3:07 PM CST

SHE:300006 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
919.68926.061,072836.44846.29559.43
Cash & Short-Term Investments
919.68926.061,072836.44846.29559.43
Cash Growth
8.20%-13.62%28.18%-1.16%51.28%2.67%
Accounts Receivable
254.9252.92286.67339.21348.39445.38
Other Receivables
200.84149.15166.75268.73312.52539.13
Receivables
455.74402.08453.42607.94660.9984.51
Inventory
151.45161.33201.7171202.4157.77
Prepaid Expenses
-7.2911.33.582.664.5
Other Current Assets
43.0824.5831.5727.2133.2320.78
Total Current Assets
1,5701,5211,7701,6461,7451,727
Property, Plant & Equipment
245.98252.17274.92286.97339.92392.49
Long-Term Investments
371.49384.12378.28519.68522.71481.36
Goodwill
44.9544.9544.9532.9432.9432.94
Other Intangible Assets
129.17131.18181.83189.3184.11116.36
Long-Term Accounts Receivable
---34.0632.41-
Long-Term Deferred Tax Assets
156.99152.39128.24132.35116.58104.62
Long-Term Deferred Charges
65.1555.5240.3627.2463.3762.53
Other Long-Term Assets
28.7833.0437.1322.1517.649.47
Total Assets
2,6122,5752,8562,8913,0552,927
Accounts Payable
9393.4865.6237.949.6334.26
Accrued Expenses
24.7199.58110.77107.55110.39109.24
Short-Term Debt
213.67179.42242.91113.5121.5130
Current Portion of Long-Term Debt
134.2131.8102.752458-
Current Portion of Leases
-3.613.654.2630.255.41
Current Income Taxes Payable
9.770.861.312.127.877.03
Current Unearned Revenue
15.6413.2113.7917.8524.0413.07
Other Current Liabilities
289.61206.54260.8255.09299.51317.8
Total Current Liabilities
780.59728.49801.61562.27701.14666.8
Long-Term Debt
47.5257.2141.45126.5149-
Long-Term Leases
1.091.463.832.536.5733.9
Long-Term Unearned Revenue
4.764.456.296.399.0412.26
Long-Term Deferred Tax Liabilities
18.8919.0519.2919.264.471.68
Other Long-Term Liabilities
---51.76--
Total Liabilities
852.85810.65972.47768.71870.22714.65
Common Stock
1,0561,0561,0561,0561,0561,056
Additional Paid-In Capital
1,5071,5071,4831,4831,4751,459
Retained Earnings
-765.68-750.67-501.33-414.9-406.22-358.52
Comprehensive Income & Other
-56.23-56.23-162.53-43.77--
Total Common Equity
1,7411,7561,8752,0812,1242,156
Minority Interest
18.728.188.0441.5160.5255.78
Shareholders' Equity
1,7601,7641,8832,1222,1852,212
Total Liabilities & Equity
2,6122,5752,8562,8913,0552,927
Total Debt
396.48373.48494.59270.79365.27219.32
Net Cash (Debt)
523.2552.58577.51565.65481.02340.11
Net Cash Growth
5.07%-4.32%2.10%17.59%41.43%-
Net Cash Per Share
0.500.520.550.540.460.34
Filing Date Shares Outstanding
1,0571,0561,0561,0561,0561,056
Total Common Shares Outstanding
1,0571,0561,0561,0561,0561,056
Working Capital
789.35792.85968.491,0841,0441,060
Book Value Per Share
1.651.661.781.972.012.04
Tangible Book Value
1,5671,5801,6491,8581,9072,007
Tangible Book Value Per Share
1.481.501.561.761.811.90
Buildings
-408.44411.75413.99412.67412.67
Machinery
-660.32652.83646.2674.06664.11
Construction In Progress
-0.6172.463.784.09
Source: S&P Global Market Intelligence. Standard template. Financial Sources.